| 2020-12-31 | Linvatec Corporation | $2,250 | Grant | In-kind items and services | MICROPOWER Device, ORTHOPEDIC SURGERY | | 2020 |
| 2020-12-31 | Siemens Medical Solutions USA, Inc. | $69 | Charitable Contribution | In-kind items and services | | | 2020 |
| 2020-12-23 | Gilead Sciences, Inc. | $9,313 | Research payment | Cash or cash equivalent | | A Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt | 2020 |
| 2020-12-23 | Abbott Laboratories | $6,240 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Confirm Rx Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-12-10 | AstraZeneca Pharmaceuticals LP | $750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | IMFINZI Drug, Oncology | | 2020 |
| 2020-12-09 | Abbott Laboratories | $290 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | | | 2020 |
| 2020-12-08 | BIOTRONIK INC. | $1,600 | Consulting Fee | Cash or cash equivalent | | | 2020 |
| 2020-12-08 | BIOTRONIK INC. | $1,200 | Consulting Fee | Cash or cash equivalent | | | 2020 |
| 2020-12-08 | BIOTRONIK INC. | $400 | Consulting Fee | Cash or cash equivalent | | | 2020 |
| 2020-12-08 | BIOTRONIK INC. | $400 | Consulting Fee | Cash or cash equivalent | | | 2020 |
| 2020-11-18 | Gilead Sciences, Inc. | $1,364 | Research payment | Cash or cash equivalent | | A Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt | 2020 |
| 2020-10-30 | Novocure Inc. | $8,588 | Research payment | Cash or cash equivalent | Optune Device, Oncology | EF-27 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and | 2020 |
| 2020-10-26 | SWEDISH ORPHAN BIOVITRUM AB | $12,296 | Research payment | Cash or cash equivalent | KINERET Drug, IMMUNOLOGY | SOBI.IMMUNO-101 | 2020 |
| 2020-10-15 | Boston Scientific Corporation | $696 | Research payment | In-kind items and services | GENERAL - TACHY Device, TACHY | LONGEVITY STUDY | 2020 |
| 2020-09-29 | Bio-Rad Laboratories, Inc. | $10,038 | Gift | Cash or cash equivalent | Liquichek Device, Controls | | 2020 |
| 2020-09-29 | Bio-Rad Laboratories, Inc. | $1,141 | Gift | Cash or cash equivalent | Digital PCR Assays Device, PCR | | 2020 |
| 2020-09-29 | Bio-Rad Laboratories, Inc. | $1,135 | Gift | Cash or cash equivalent | Lipid Transfection Reagents Device, Not Applicable | | 2020 |
| 2020-09-29 | Bio-Rad Laboratories, Inc. | $1,135 | Gift | Cash or cash equivalent | Lipid Transfection Reagents Device, Not Applicable | | 2020 |
| 2020-09-28 | Abbott Laboratories | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | | | 2020 |
| 2020-09-23 | Gilead Sciences, Inc. | $1,364 | Research payment | Cash or cash equivalent | | A Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt | 2020 |
| 2020-09-17 | Abbott Laboratories | $4,615 | Research payment | Cash or cash equivalent | ABSORB Device, Vascular | ABSORB III Randomized Controlled Trial (RCT) (ABSORB-III) | 2020 |
| 2020-09-17 | Abbott Laboratories | $3,900 | Research payment | Cash or cash equivalent | ABSORB Device, Vascular | ABSORB III Randomized Controlled Trial (RCT) (ABSORB-III) | 2020 |
| 2020-09-17 | Linvatec Corporation | $2,151 | Grant | In-kind items and services | FLUID MANAGEMENT/PUMPS Device, ORTHOPEDIC SURGERY | | 2020 |
| 2020-08-25 | Novocure Inc. | $13,490 | Research payment | Cash or cash equivalent | Optune Device, Oncology | EF-24 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapi | 2020 |
| 2020-08-25 | Novocure Inc. | $11,506 | Research payment | Cash or cash equivalent | Optune Device, Oncology | EF-24 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapi | 2020 |
| 2020-08-24 | Gilead Sciences, Inc. | $19,433 | Research payment | Cash or cash equivalent | Veklury Drug, COVID-19 | Phase 3 Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Remdesivir (GS-5734) tre | 2020 |
| 2020-08-14 | Pacira Therapeutics, Inc. | $24,113 | Research payment | Cash or cash equivalent | | A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Pat | 2020 |
| 2020-07-28 | BIOTRONIK INC. | $400 | Consulting Fee | Cash or cash equivalent | | | 2020 |
| 2020-07-22 | Novocure Inc. | $14,779 | Research payment | Cash or cash equivalent | Optune Device, Oncology | EF-27 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and | 2020 |
| 2020-07-09 | Abbott Laboratories | $1,248 | Consulting Fee | Cash or cash equivalent | Fortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-07-09 | Abbott Laboratories | $660 | Consulting Fee | Cash or cash equivalent | Fortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-07-09 | Abbott Laboratories | $660 | Consulting Fee | Cash or cash equivalent | Fortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-07-09 | Abbott Laboratories | $624 | Consulting Fee | Cash or cash equivalent | Fortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-07-09 | Abbott Laboratories | $624 | Consulting Fee | Cash or cash equivalent | Fortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-07-09 | Abbott Laboratories | $624 | Consulting Fee | Cash or cash equivalent | Fortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-07-09 | Abbott Laboratories | $624 | Consulting Fee | Cash or cash equivalent | Fortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-07-09 | Abbott Laboratories | $624 | Consulting Fee | Cash or cash equivalent | Fortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-07-09 | Abbott Laboratories | $624 | Consulting Fee | Cash or cash equivalent | Fortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-07-09 | Abbott Laboratories | $624 | Consulting Fee | Cash or cash equivalent | Fortify Assura Ellipse ICD Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-07-06 | Genentech USA, Inc. | $3,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Activase Biological, Metabolism & Primary Care | | 2020 |
| 2020-06-16 | Abbott Laboratories | $325 | Research payment | Cash or cash equivalent | Xience Sierra Coronary Stent System Device, Vascular | XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients | 2020 |
| 2020-05-04 | Gilead Sciences, Inc. | $17,069 | Research payment | Cash or cash equivalent | | A Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS 6207 in Combination with an Opt | 2020 |
| 2020-05-04 | Gilead Sciences, Inc. | $17,069 | Research payment | Cash or cash equivalent | | A Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhib | 2020 |
| 2020-04-13 | FUJIFILM Healthcare Americas Corporation | $614 | Gift | In-kind items and services | ESD - Core Endoscopy Device, Medical Device | | 2020 |
| 2020-04-07 | Boston Scientific Corporation | $9,193 | Charitable Contribution | In-kind items and services | General Therapies Device, General | | 2020 |
| 2020-03-31 | BIOTRONIK INC. | $12,359 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-03-12 | Abbott Laboratories | $1,495 | Research payment | Cash or cash equivalent | ABSORB Device, Vascular | ABSORB III Randomized Controlled Trial (RCT) (ABSORB-III) | 2020 |
| 2020-03-06 | Novocure Inc. | $8,030 | Research payment | Cash or cash equivalent | Optune Device, Oncology | EF-24 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapi | 2020 |
| 2020-02-27 | LANTHEUS MEDICAL IMAGING, INC. | $1,750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | DEFINITY Drug, CONTRAST AGENT | | 2020 |
| 2020-02-26 | Abbott Laboratories | $565 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | | | 2020 |
| 2020-02-26 | Abbott Laboratories | $565 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | | | 2020 |
| 2020-02-25 | AstraZeneca Pharmaceuticals LP | $1,750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | LOKELMA Drug, Cardiovascular and Metabolism | | 2020 |
| 2020-02-12 | Abbott Laboratories | $1,750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Cardiac Mapping System Device, Cardiac Arrhythmias and Heart Failure | | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $290 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $269 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $269 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $269 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $248 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $248 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $206 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $206 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $131 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $131 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $110 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $110 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $84 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $84 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $42 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $42 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $32 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $32 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $32 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $32 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-29 | Smith+Nephew, Inc. | $3,606 | Gift | In-kind items and services | GENESIS II Device, Recon Knees | | 2020 |
| 2020-01-20 | Abbott Laboratories | $325 | Research payment | Cash or cash equivalent | Xience Sierra Coronary Stent System Device, Vascular | XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients | 2020 |
| 2020-01-15 | Novocure Inc. | $4,945 | Research payment | Cash or cash equivalent | Optune Device, Oncology | EF-24 Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapi | 2020 |
| 2020-01-13 | Novartis Pharmaceuticals Corporation | $64,211 | Research payment | Cash or cash equivalent | ENTRESTO Drug, CARDIOVASCULAR | PROSPECTIVE COMPARISON OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR ARNI VERSUS ACE INHIBITOR TRIAL TO DETERMINE IMPACT | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $347 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $269 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $269 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $269 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $32 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $32 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-08 | BIOTRONIK INC. | $32 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-01 | Surgical Theater. Inc. | $72,000 | Gift | In-kind items and services | | | 2020 |
| 2020-01-01 | Surgical Theater. Inc. | $72,000 | Gift | In-kind items and services | | | 2020 |
Comments